Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0360220230640010035
Journal of the Korean Ophthalmological Society
2023 Volume.64 No. 1 p.35 ~ p.42
The Choroidal Vascularity Indices of Treatment-Naive Patients with Central Retinal Vein Occlusion and Age-/Sex-Matched Controls
Joo Hye-Jun

Kim Ha-Kyoung
Ma Dae-Joong
Mun Yong-Seok
Abstract
Purpose: To compare the subfoveal choroidal vascularity indices (CVIs) of treatment-naive patients with central retinal vein occlusion (CRVO) with controls.

Methods: Twenty-one eyes of 21 treatment-naive CRVO patients and 42 age- and sex-matched control eyes (of 42 subjects) lacking any retinal disease were included. The subfoveal CVIs were measured using ImageJ software.

Results: The mean subfoveal CVI in eyes with treatment-naive CRVO at the initial visit was significantly higher than that of control eyes (0.6464 ¡¾ 0.0326 vs. 0.6209 ¡¾ 0.0434 respectively; p = 0.024). In contrast, no significant difference in the mean subfoveal CVI was found between CRVO eyes 6 months after initial diagnosis and control eyes (0.6311 ¡¾ 0.0600 vs. 0.6209 ¡¾ 0.0434 respectively; p = 0.238). Of the 21 eyes with CRVO, 18 (85.7%) received intravitreal injections (bevacizumab, ranibizumab, aflibercept, or triamcinolone) and four (19.0%) underwent panretinal photocoagulation.

Conclusions: The subfoveal CVI of eyes with treatment-naive CRVO at the initial visit was significantly higher than that of control eyes, but decreased by 6 months. Further studies are needed to determine whether CRVO treatments such as intravitreal injection or panretinal photocoagulation affect choroid hemodynamics.
KEYWORD
Central retinal vein occlusion, Choroidal vascularity index
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø